These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 20416263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids.
    Russell AF, Parrino J, Fisher CL, Spieler W, Stek JE, Coll KE, Su SC, Xu J, Li X, Schlienger K, Silber JL.
    Vaccine; 2015 Jun 17; 33(27):3129-34. PubMed ID: 25964168
    [Abstract] [Full Text] [Related]

  • 3. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
    Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, Barben JL, Rarrick K, Stek JE, Chung MO, Schödel FP, Wang WW, Xu J, Chan IS, Silber JL, Schlienger K.
    J Am Geriatr Soc; 2007 Oct 17; 55(10):1499-507. PubMed ID: 17908055
    [Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.
    Tyring SK, Diaz-Mitoma F, Padget LG, Nunez M, Poland G, Cassidy WM, Bundick ND, Li J, Chan IS, Stek JE, Annunziato PW, Protocol 009 Study Group.
    Vaccine; 2007 Feb 26; 25(10):1877-83. PubMed ID: 17227688
    [Abstract] [Full Text] [Related]

  • 5. Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age.
    Vermeulen JN, Lange JM, Tyring SK, Peters PH, Nunez M, Poland G, Levin MJ, Freeman C, Chalikonda I, Li J, Smith JG, Caulfield MJ, Stek JE, Chan IS, Vessey R, Schödel FP, Annunziato PW, Schlienger K, Silber JL.
    Vaccine; 2012 Jan 20; 30(5):904-10. PubMed ID: 22154769
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults.
    Choi WS, Choi JH, Choi JY, Eom JS, Kim SI, Pai H, Peck KR, Sohn JW, Cheong HJ.
    J Korean Med Sci; 2016 Jan 20; 31(1):13-7. PubMed ID: 26770032
    [Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults.
    Macaladad N, Marcano T, Guzman M, Moya J, Jurado F, Thompson M, Meechan C, Li D, Schlienger K, Chan I, Sadoff J, Schödel F, Silber JL.
    Vaccine; 2007 Mar 01; 25(11):2139-44. PubMed ID: 17250932
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
    Levin MJ, Buchwald UK, Gardner J, Martin J, Stek JE, Brown E, Popmihajlov Z.
    Vaccine; 2018 Jan 02; 36(1):179-185. PubMed ID: 28830693
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
    Godeaux O, Kovac M, Shu D, Grupping K, Campora L, Douha M, Heineman TC, Lal H.
    Hum Vaccin Immunother; 2017 May 04; 13(5):1051-1058. PubMed ID: 28068212
    [Abstract] [Full Text] [Related]

  • 10. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
    Diez-Domingo J, Weinke T, Garcia de Lomas J, Meyer CU, Bertrand I, Eymin C, Thomas S, Sadorge C.
    Vaccine; 2015 Feb 04; 33(6):789-95. PubMed ID: 25555381
    [Abstract] [Full Text] [Related]

  • 11. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ, Euler GL, Jumaan AO, Harpaz R.
    Vaccine; 2009 Feb 05; 27(6):882-7. PubMed ID: 19071175
    [Abstract] [Full Text] [Related]

  • 12. The immunogenicity and safety of zoster vaccine in Taiwanese adults.
    Yao CA, Chen LK, Huang KC.
    Vaccine; 2015 Mar 24; 33(13):1515-7. PubMed ID: 25681662
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.
    Mullane KM, Winston DJ, Wertheim MS, Betts RF, Poretz DM, Camacho LH, Pergam SA, Mullane MR, Stek JE, Sterling TM, Zhao Y, Manoff SB, Annunziato PW.
    J Infect Dis; 2013 Nov 01; 208(9):1375-85. PubMed ID: 23908479
    [Abstract] [Full Text] [Related]

  • 16. Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Eberhardson M, Hall S, Papp KA, Sterling TM, Stek JE, Pang L, Zhao Y, Parrino J, Popmihajlov Z.
    Clin Infect Dis; 2017 Oct 01; 65(7):1174-1182. PubMed ID: 29126292
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old.
    MacIntyre CR, Egerton T, McCaughey M, Parrino J, Campbell BV, Su SC, Pagnoni MF, Stek JE, Xu J, Annunziato PW, Chan IS, Silber JL.
    Hum Vaccin; 2010 Nov 01; 6(11):894-902. PubMed ID: 20980796
    [Abstract] [Full Text] [Related]

  • 19. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults.
    Chlibek R, Pauksens K, Rombo L, van Rijckevorsel G, Richardus JH, Plassmann G, Schwarz TF, Catteau G, Lal H, Heineman TC.
    Vaccine; 2016 Feb 03; 34(6):863-8. PubMed ID: 26432913
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
    Tseng HF, Smith N, Sy LS, Jacobsen SJ.
    Vaccine; 2011 May 09; 29(20):3628-32. PubMed ID: 21435407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.